Clinical Trial Update: Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase II trial evaluating a Farnesyltransferase inhibitor (FTI) for advanced multiple myeloma has completed. The document notes completion of the study but does…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• FTase Inhibitor (FTI) (farnesyltransferase inhibitor)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED